ASC trends

Cost-Conscious ASCs Seek Sourcing Strategies

Vizient launched a first-of-its-kind sourcing program that targets ASCs. The initiative serves as an example of the evolving opportunities the ASC market will open for industry in the years ahead.

The Numbers
Over the last four years, spine M&A volume declined significantly while digital and orthobiologic assets saw increased activity.

Digital and Obio Assets in Greater Demand for M&A

Over the last four years, spine M&A volume declined significantly while digital and orthobiologic assets saw increased activity.

Enabling technology is disrupting the competitive dynamics of the biggest orthopedic markets like joint replacement and spine.

Enabling Technology Creates a New Basis for Competition

Enabling technology is disrupting the competitive dynamics of the biggest orthopedic markets like joint replacement and spine.

Orthoflash®
Exactech GPS Ankle Navigation
First Use of Exactech GPS Ankle Ex-US

The system was first launched in the U.S. in 2024, and is compatible with the company’s flagship Vantage Total Ankle System.

,
Pixee Medical Receives FDA 510(k) Clearance for Augmented Reality solution
Pixee Medical Granted FDA 510(k) Clearance of Knee+ NexSight

This next-generation of augmented reality was designed to address the ambulatory surgical center market.

,
LEM Surgical Dynamis Robotic Surgical System
LEM Surgical Gains 510(k) for Dynamis Robotic Surgical System

Dynamis is an integrated navigation-based robotic platform designed to enhance accuracy and control during spine surgeries.

,
Xtant Medical Launches Trivium Advanced Bone Graft
Xtant Medical Launches Trivium Advanced Bone Graft

Engineered with PureLoc Fiber Technology, Trivium combines synergistic elements intended to elevate performance in structure, handling, and biological activity.

,
CGBIO Gains Approval for NOVOSIS Putty Trial
CGBIO Gains Approval for NOVOSIS Putty Trial

The bone graft incorporating rhBMP-2 received FDA Investigational Device Exemption approval for a pivotal clinical trial in spinal fusion.

,
Competitive Landscape
Industry Voices

Contact Us

0